Due to concerns over hepatotoxicity, several countries have implemented regulatory restrictions on kava products. For instance, kava was banned in several European countries and Canada, although some have since lifted or relaxed these bans. In the United States, kava is available as a dietary supplement, but the FDA has issued consumer advisories regarding its potential risks. Regulatory approaches vary widely, reflecting differences in the interpretation of available safety data.
